Nav: Home

Academics call for Parliament to tackle the privatization of NHS

March 24, 2017

A bill to prevent the privatisation of NHS services and to reinstate the NHS in England, supported and written by Newcastle University academics, is scheduled to be debated today.

On Friday 24th March, the NHS Reinstatement Bill will be presented in the House of Commons by Margaret Greenwood, Labour MP for Wirral West.

It is the result of a body of work by Newcastle University academic Professor Alyson Pollock and colleague, barrister Peter Roderick.

Professor Pollock, the newly-appointed Director of the Institute of Health and Society, Newcastle University, said: "The NHS has been one of the UK's greatest achievements and for almost 70 years it has provided a cost effective, universal health service. Yet this has been eroded.

"I believe the Health and Social Care Act 2012, forced a commercialised model on the NHS in England as the first thing it did was remove the duty on the Health Secretary to provide services throughout England. In effect this makes commercial tendering virtually compulsory.

"The result is billions of pounds of NHS money and thousands of health services put out to commercial tendering, removing scarce resources from the system and putting them into the private sector instead.

"The aim of today's Bill is to force the issue into the open, and allow debate on what I consider as a momentous failing to society."

The Bill proposes that the NHS should be restored as a public service by reversing marketization in the NHS, by abolishing the purchaser-provider split ending contracting and re-establishing public bodies and public services accountable to local communities.

The academic team believe this is necessary to stop the dismantling of the NHS under the Health and Social Care Act 2012.

Allyson Pollock was professor of public health research and policy at Queen Mary University of London, and set up and directed the Centre for International Public Health Policy at the University of Edinburgh before moving to Newcastle.

Her research at Newcastle University will focus on health inequalities, the privatisation and marketization of health services, pharmaceuticals and clinical trials and will build on her well-respected work on sports injury, in particular head injuries.

The Bill was co-written with the help of Peter Roderick, Principal Research Associate within the Institute of Health and Society.

He said: "In writing this bill, we are reinstating the founding principles which made the NHS. These have been eroded and they will not be restored unless Parliament passes a law to do so."

MP Margaret Greenwood took up the Bill because of growing public concern about the state of the NHS and she is calling on people concerned about the NHS to write to their MP to ask them to support the Bill.

Another key supporter of the Bill is MP for North Tyneside, Mary Glindon.
-end-


Newcastle University

Related Clinical Trials Articles:

Giving children a voice in clinical trials
Children as young as 8 years old with incurable cancer can reliably characterize the impact an experimental therapy has on their symptoms and quality of life -- even at the earliest stages of drug development -- making self-reported patient outcomes a potential new clinical trial endpoint.
Better health for women involved in clinical trials
Women who participate in obstetric and gynecology clinical trials experience improved health outcomes compared to those who are not involved in trials, according to research by Queen Mary University of London.
Final artificial pancreas clinical trials now open
Clinical trials are now enrolling to provide the final tests for a University of Virginia-developed artificial pancreas to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes.
Why the bar needs to be raised for human clinical trials
Standards for authorizing first-time trials of drugs in humans are lax, and should be strengthened in several ways, McGill University researchers argue in a paper published today in Nature.
New drug formulary will help expedite use of agents in clinical trials
The National Cancer Institute (NCI) today launched a new drug formulary (the 'NCI Formulary') that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials.
Review examines diversity in dermatology clinical trials
Racial and ethnic groups can be underrepresented in medical research.
Reshaping the future of global clinical trials practice
Researchers at the University of Liverpool have developed a new international guideline to help standardize how results from clinical trial studies are reported.
Fewer cardiovascular drugs being studied in clinical trials
The number of cardiovascular drugs in the research pipeline has declined across all phases of development in the last 20 years even as cardiovascular disease has become the No.
Sex hormones skew outcomes in clinical trials -- here's how
Clinical research often excludes females from their trials under the assumption that 'one size fits all,' that a painkiller or antidepressant will be equally effective in subjects of either sex, but a growing number of scientists are criticizing this approach.
Nearly half of pediatric clinical trials go unfinished or unpublished
Clinical trials in children commonly go either uncompleted or unpublished, finds a comprehensive study conducted by researchers at Boston Children's Hospital.

Related Clinical Trials Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...